“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.
Meanwhile, the Maryland State Medical Society is formally urging the administration to reject the mid-year request, contending it will harm patients and providers.
John S. Scales, MD, a vascular and interventional specialist with Radiology Associates of Ocala in central Florida, has agreed to the terms, according to the state.
For the first time, research has identified diaphragmatic dome height measured on chest X-rays as an indicator of what patients’ post-op recovery will look like following surgery for cancer or other lung disorders.
“Radiologists are well-positioned to contribute evidence-based guidance, promote transparency, and help patients make informed decisions," experts write in Clinical Imaging.
Vanderbilt experts have developed an assessment called MyProstateScore 2.0–Active Surveillance, which they say performs better than regular PSA-based testing and MRI for monitoring low-risk disease.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.
